BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
Yokota, T, Ura, T, Shibata, N, Takahari, D, Shitara, K, Nomura, M, Kondo, C, Mizota, A, Utsunomiya, S, Muro, K, Yatabe, Y
Published in British journal of cancer (01.03.2011)
Published in British journal of cancer (01.03.2011)
Get full text
Journal Article
Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial
Yamazaki, K., Yamanaka, T., Shiozawa, M., Manaka, D., Kotaka, M., Gamoh, M., Shiomi, A., Makiyama, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Ueki, T., Shitara, K., Shinkai, H., Tanida, N., Oki, E., Sunami, E., Ohtsu, A., Maehara, Y., Yoshino, T.
Published in Annals of oncology (01.01.2021)
Published in Annals of oncology (01.01.2021)
Get full text
Journal Article
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
Muro, K., Van Cutsem, E., Narita, Y., Pentheroudakis, G., Baba, E., Li, J., Ryu, M -H, Zamaniah, W I Wan, Yong, W -P, Yeh, K -H, Kato, K., Lu, Z., Cho, B.C., Nor, I.M., Ng, M., Chen, L -T, Nakajima, T.E., Shitara, K., Kawakami, H., Tsushima, T., Yoshino, T., Lordick, F., Martinelli, E., Smyth, E.C., Arnold, D., Minami, H., Tabernero, J., Douillard, J -Y
Published in Annals of oncology (01.01.2019)
Published in Annals of oncology (01.01.2019)
Get full text
Journal Article
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
Muro, K., Lordick, F., Tsushima, T., Pentheroudakis, G., Baba, E., Lu, Z., Cho, B.C., Nor, I.M., Ng, M., Chen, L -T, Kato, K., Li, J., Ryu, M -H, Zamaniah, W I Wan, Yong, W -P, Yeh, K -H, Nakajima, T.E., Shitara, K., Kawakami, H., Narita, Y., Yoshino, T., Van Cutsem, E., Martinelli, E., Smyth, E.C., Arnold, D., Minami, H., Tabernero, J., Douillard, J -Y
Published in Annals of oncology (01.01.2019)
Published in Annals of oncology (01.01.2019)
Get full text
Journal Article
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma
Shitara, K., Özgüroğlu, M., Bang, Y.-J., Di Bartolomeo, M., Mandalà, M., Ryu, M.-H., Caglevic, C., Chung, H.C., Muro, K., Van Cutsem, E., Kobie, J., Cristescu, R., Aurora-Garg, D., Lu, J., Shih, C.-S., Adelberg, D., Cao, Z.A., Fuchs, C.S.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients
Shitara, K., Yamanaka, T., Denda, T., Tsuji, Y., Shinozaki, K., Komatsu, Y., Kobayashi, Y., Furuse, J., Okuda, H., Asayama, M., Akiyoshi, K., Kagawa, Y., Kato, T., Oki, E., Ando, T., Hagiwara, Y., Ohashi, Y., Yoshino, T.
Published in Annals of oncology (01.02.2019)
Published in Annals of oncology (01.02.2019)
Get full text
Journal Article
Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer
Kubota, Y., Kawazoe, A., Mishima, S., Nakamura, Y., Kotani, D., Kuboki, Y., Bando, H., Kojima, T., Doi, T., Yoshino, T., Kuwata, T., Shitara, K.
Published in ESMO open (01.02.2023)
Published in ESMO open (01.02.2023)
Get full text
Journal Article
Timing of Initiation of Adjuvant Chemotherapy for Gastric Cancer: A Case-Matched Comparison Study of Laparoscopic vs. Open Surgery
Kaito, Akio, MD, Kinoshita, Takahiro, MD, PhD, FACS, Shitara, Kouhei, MD, PhD, Shibasaki, Hidehito, MD, PhD, Nishida, Toshirou, MD, PhD, FACS
Published in European journal of surgical oncology (01.04.2017)
Published in European journal of surgical oncology (01.04.2017)
Get full text
Journal Article
195TiP GLOW: Phase III study of first-line zolbetuximab + CAPOX versus placebo + CAPOX in Claudin18.2⁺/HER2⁻ advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)
Xu, R-H., Ajani, J.A., Al-Batran, S-E., Bang, Y-J., Catenacci, D., Enzinger, P.C., Ilson, D.H., Kim, S., Lordick, F., Shitara, K., van Cutsem, E., Arozullah, A., Park, J.W., Shah, M.A.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
583P Effect of infusion rate, premedication, and prophylactic peg-filgrastim treatment on the safety of the liposomal formulation of eribulin (E7389-LF): Results from the expansion part of a phase I study
Iwasa, S., Takahashi, S., Hirao, M., Kato, K., Shitara, K., Sato, Y., Hamakawa, T., Horinouchi, H., Tahara, M., Chin, K., Mizutani, M., Suzuki, T., Takase, T., Matsunaga, R., Mukohara, T.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Role of Nivolumab in the Management of First-Line Unresectable Advanced or Recurrent Gastric Cancer in Combination with Chemotherapy: Lessons from the Japanese Experience
Kubota, Yohei, Aoki, Yu, Kawazoe, Akihito, Shitara, Kohei
Published in Cancer management and research (01.01.2022)
Published in Cancer management and research (01.01.2022)
Get full text
Journal Article
A randomized, phase II, multicenter, open-label study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing gastric cancer
Shitara, K., Bang, Y.-J., Sakai, D., Yasui, H., Kawaguchi, Y., Sugihara, M., Saito, K., Dalal, R., Yamaguchi, K.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Safety and efficacy of trifluridine/tipiracil (TAS-102) plus bevacizumab in clinical practice for patients with refractory metastatic colorectal cancer
Kotani, D., Kuboki, Y., Yasuda, K., Nakamura, Y., Kawazoe, A., Bando, H., Taniguchi, H., Shitara, K., Yoshino, T.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Relation of overall survival, progression free survival, post progression survival and response rate in four randomized Japanese phase III trials comparing various combinations of S-1 therapy for first-line treatment of advanced gastric cancer
Takeuchi, M., Ichikawa, W., Shitara, K., Sunakawa, Y., Oba, K., Koizumi, W., Sakata, Y., Furukawa, H., Takeuchi, M., Fujii, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
LBA6_PR Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study
Moehler, M., Shitara, K., Garrido, M., Salman, P., Shen, L., Wyrwicz, L., Yamaguchi, K., Skoczylas, T., Campos Bragagnoli, A., Liu, T., Schenker, M., Yanez, P., Tehfe, M., Poulart, V., Cullen, D., Lei, M., Kondo, K., Li, M., Ajani, J.A., Janjigian, Y.Y.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
The nationwide cancer genome screening project in Japan, SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced esophageal cancer
Kato, K., Kojima, T., Saeki, H., Hara, H., Kajiwara, T., Hironaka, S., Nakatsumi, H., Kadowaki, S., Kagawa, Y., Esaki, T., Moriwaki, T., Kobayashi, T., Izawa, N., Nomura, S., Kuwata, T., Fujii, S., Okamoto, W., Shitara, K., Ohtsu, A., Yoshino, T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
The nationwide cancer genome screening project in Japan, SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced pancreatic cancer
Izawa, N., Morizane, C., Takahashi, H., Ueno, M., Kawamoto, Y., Okano, N., Shimizu, S., Sudo, K., Itoh, S., Asagi, A., Kagawa, Y., Kamata, K., Kudo, T., Nomura, S., Kuwata, T., Fujii, S., Okamoto, W., Shitara, K., Ohtsu, A., Yoshino, T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer: a double-blind, randomized, placebo-controlled phase 3 study
Chung, H., Bang, Y., Fuchs, C., Qin, S., Satoh, T., Shitara, K., Tabernero, J., Van Cutsem, E., Cao, Z., Chen, X., Kang, S., Shih, C., Janjigian, Y.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article